Sally OBE - Life Science Independent Director
| LABS Stock | 38.60 0.10 0.26% |
Director
Sally OBE is Independent Director of Life Science REIT
| Age | 62 |
| Address | Central Square, Leeds, United Kingdom, LS1 4DL |
| Phone | 44 20 7945 9566 |
| Web | https://www.lifesciencereit.co.uk |
Life Science Management Efficiency
The company has return on total asset (ROA) of 0.014 % which means that it generated a profit of $0.014 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1377) %, meaning that it generated substantial loss on money invested by shareholders. Life Science's management efficiency ratios could be used to measure how well Life Science manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Life Science's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 420.4 M in 2024, despite the fact that Other Assets are likely to grow to (3.8 M).Similar Executives
| Found 8 records | DIRECTOR Age | ||
| Howard Ebison | Hammerson PLC | N/A | |
| ACA AMCT | DS Smith PLC | 54 | |
| Helen McCabe | Rolls Royce Holdings PLC | 55 | |
| Himanshu Raja | Hammerson PLC | 59 | |
| Josh Warren | Hammerson PLC | N/A | |
| Vakhtang Bobokhidze | Bank of Georgia | N/A | |
| Michael Carey | Supermarket Income REIT | N/A | |
| Keith Tornes | DS Smith PLC | N/A | |
Management Performance
| Return On Equity | -0.14 | ||||
| Return On Asset | 0.014 |
Life Science REIT Leadership Team
Elected by the shareholders, the Life Science's board of directors comprises two types of representatives: Life Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Life. The board's role is to monitor Life Science's management team and ensure that shareholders' interests are well served. Life Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Life Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tamara Deering, Head Reporting | ||
| Pippa Stacey, Head Consultant | ||
| Daniel Williams, Corporate Limited | ||
| Simon Farnsworth, Managing Director | ||
| Stephanie Adams, Legal Counsel | ||
| Joanna Waddingham, Head Limited | ||
| Sally OBE, Independent Director | ||
| Ian Harris, Director Management | ||
| David Lewis, Director Limited |
Life Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Life Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | ||||
| Return On Asset | 0.014 | ||||
| Profit Margin | (1.99) % | ||||
| Operating Margin | 0.50 % | ||||
| Current Valuation | 239.64 M | ||||
| Shares Outstanding | 350 M | ||||
| Shares Owned By Insiders | 7.11 % | ||||
| Shares Owned By Institutions | 70.21 % | ||||
| Price To Book | 0.50 X | ||||
| Price To Sales | 6.71 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.